期刊文献+

免疫磁珠分选和MLPA技术联合检测多发性骨髓瘤分子遗传学异常系统的建立 被引量:3

Magnetic-activated cell sorting combined with multiplex ligation-dependent probe amplification for detecting molecular cytogenetic abnormalities in multiple myeloma
在线阅读 下载PDF
导出
摘要 目的探讨联合免疫磁珠分选和多重探针连接依赖性扩增(MLPA)技术检测多发性骨髓瘤(MM)分子遗传学异常的可靠性。方法收集29例初诊MM患者的骨髓细胞,用CD138磁珠进行分选,设计MLPA探针检测分选前后标本TP53和RB1的表达情况,并与FISH检测结果进行对照。结果 MLPA检测成功率100%,与FISH结果吻合度达99.1%,分选后MLPA和FISH阳性率均有显著性提高。结论 MLPA适合临床MM分子遗传学异常检测,标本应在检测前进行磁珠分选。 Objective To investigate the reliability of magnetic-activated cell sorting (MACS) combined with multiplex ligation-dependent probe amplification (MLPA) in the detection of the molecular cytogenetic abormalities in multiple myeloma. Methods The bone marrow ceils were colelcted from 29 patients with multiple myeloma. The irnmunomagnetically sorted and unsorted ceils were detected for TP53 and RB1 expressions using MLPA probes and the results were compared with fluorescent in situ hybridization (FISH). Results The detection success rate was 100% for MLPA, which yielded results with an concordance rate of 99.1% with the FISH results. The positivity rates of MLPA and FISH were both increased after immunomagnetic sorting of the bone marrow cells. Conclusion MLPA can well suit the clinical needs for detecting molecular cytogenetic abnormalities in multiple myeloma, and the samples should be immunomagnetically sorted before the assay.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2012年第9期1332-1335,共4页 Journal of Southern Medical University
基金 广东省科技计划项目(2010B031900037)
关键词 多发性骨髓瘤 多重连接依赖性扩增 荧光原位杂交 免疫磁珠分选 multiple myeloma multiplex ligation dependent probe amplification fluorescene in situ hybridization immunomagnetic sorting
  • 相关文献

参考文献14

  • 1Fonseca R, Bergsagel PL, Avet-Loiseau H, et al. International Myeloma Working Group molecular classfication of multiple myeloma: spotlight review [J]. Leukemia, 2009, 23(12): 2210-21.
  • 2Chen LJ, Li JY, Xu W, et al. Molecular cytogenetic abnormalities in patients with multiple myeloma studied by interphase fluorescence in itu hybridization [J]. Exp Oneol, 2007, 29(2): 116-20.
  • 3Schouten JP, McElgunn CJ, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification[J]. Nucleic Acids Res, 2002, 30(12): e57.
  • 4Fabris S, Scarciolla O, Morabito F, et al. Multiplex ligation- dependent probe amplification and fluorescence in sire hybridizationto detect chromosomal abnormalities in chronic lymphocytic leukemia: a comparative study[J]. Genes Chromosomes Cancer, 2011, 50(9): 726-34.
  • 5Donahue AC, Abdool AK, Gaur R, et al. Multiplex ligation- dependent probe amplification for detection of ehromosomal abnormalities in myelodysplastic syndrome and acute myeloid leukemia[J]. Leuk Res, 2011, 35(11): 1477-83.
  • 6Cechova H, Lassuthova P, Novakova L, et al. Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia [J]. Neoplasma, 2012, 59(2): 168-74.
  • 7安刚,李承文,李倩,易树华,刘旭平,徐燕,李增军,齐军元,邹德慧,邱录贵.免疫磁珠分选对荧光原位杂交检测多发性骨髓瘤细胞遗传学异常的影响[J].中国实验血液学杂志,2011,19(1):54-58. 被引量:18
  • 8Cumova J, Kovarova L, Potacova A, et al. Optimization of immunomagnetic selection of myeloma ceils from bone marrow using magnetic activated cell sorting[J]. Int J Hematol, 2010, 92(2): 314-9.
  • 9Van Opstal D, Boter M, de Jong D, et al. Rapid aneuploidy detection with multiplex ligation-dependent probe amplification: a prospective study of 4000 amniotic fluid samples [J]. Eur J Hum Genct, 2009, 17(1): 112-21.
  • 10Bravaccini S, Rengucci C, Medri L, et al. Detection of HER2 and Topo 2 in breast cancers: comparison between MLPA and FISH approaches[J]. J Clin Pathol, 2012, 65(2): 183-5.

二级参考文献8

  • 1刘淑艳,李建勇,陈丽娟,黄金文,潘金兰,仇海荣,沈云峰,徐卫,薛永权.多发性骨髓瘤分子细胞遗传学异常的研究[J].中华血液学杂志,2007,28(4):223-226. 被引量:8
  • 2Kapoor P, Fonseca R, Rajkumar SV, et al. Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie. Mayo Clin Proc, 2010; 85(6) : 532 -537.
  • 3Fonseca R, Bergsagel PL, Drach J, et al. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia, 2009 ;23 (12) :2210 - 2021.
  • 4Fonseca R, Barlogie B, Bataille R, et al. Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res, 2004 ; 64(4) : 1546 - 1558.
  • 5Avet-Loiseau H, Facon T, Grosbois B, et al. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. Blood, 2002 ; 99 ( 6 ) : 2185 -2191.
  • 6Smejkalova J, Vranova V, Oltova A, et al. Comparison of standard prognostic factors with the deletion of 13q14 detected by interphase fluorescence in situ hybridization on separated and unseparated bone marrow cells in multiple myeloma. Cas Lek Cesk, 2005 ; 144(7) : 483 -488.
  • 7陈丽娟,李建勇,朱雨,仇海荣,张苏江,钱思轩,徐卫,陆化.采用探针D13S319和D13S25检测多发性骨髓瘤13q14缺失[J].中华医学遗传学杂志,2008,25(5):597-598. 被引量:1
  • 8李倩鲁云王亚非刘旭平齐军元邹德慧赵耀中邱录贵.荧光原位杂交检测多发性骨髓瘤患者△13及其临床意义[J].中华医学杂志,2009,89(28):1979-1982. 被引量:10

共引文献17

同被引文献29

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部